Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 335 Records) |
| Query Trace: Breast Neoplasms and ATM[original query] |
|---|
| BRCA1 transports the DNA damage signal for CDDP-induced centrosome amplification through the centrosomal Aurora A. Cancer science 2022 9 113 (12): 4230-4243. Qi Huicheng, Kikuchi Megumi, Yoshino Yuki, Fang Zhenzhou, Ohashi Kazune, Gotoh Takato, Ideta Ryo, Ui Ayako, Endo Shino, Otsuka Kei, Shindo Norihisa, Gonda Kohsuke, Ishioka Chikashi, Miki Yoshio, Iwabuchi Tokuro, Chiba Natsu |
| ATM c.7570G>C is a high-risk allele for breast cancer. International journal of cancer 2022 9 152 (3): 429-435. Kankuri-Tammilehto Minna, Tervasmäki Anna, Kraatari-Tiri Minna, Rahikkala Elisa, Pylkäs Katri, Kuismin Ou |
| SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk. Journal of cancer research and clinical oncology 2022 Sep . Vuorinen Sofia I, Okolicsanyi Rachel K, Gyimesi Martina, Meyjes-Brown Jacob, Saini Deepa, Pham Son H, Griffiths Lyn R, Haupt Larisa |
| Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases. Journal of medical genetics 2022 9 . Lakeman Inge M M, Rodríguez-Girondo Mar D M, Lee Andrew, Celosse Nandi, Braspenning Merel E, van Engelen Klaartje, van de Beek Irma, van der Hout Annemiek H, Gómez García Encarna B, Mensenkamp Arjen R, Ausems Margreet G E M, Hooning Maartje J, Adank Muriel A, Hollestelle Antoinette, Schmidt Marjanka K, van Asperen Christi J, Devilee Pet |
| Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes. Annals of oncology : official journal of the European Society for Medical Oncology 2022 Sep . Loveday C, Garrett A, Law P, Hanks S, Poyastro-Pearson E, Adlard J W, Barwell J, Berg J, Brady A F, Brewer C, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison P J, Paterson J, Porteous M, Rogers M T, Walker L, , Eccles D, Evans D G, Snape K, Hanson H, Houlston R S, Turnbull |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. Frontiers in oncology 2022 12 976959. Paixão Daniele, Torrezan Giovana Tardin, Santiago Karina Miranda, Formiga Maria Nirvana, Ahuno Samuel Terkper, Dias-Neto Emmanuel, Tojal da Silva Israel, Foulkes William D, Polak Paz, Carraro Dirce Mar |
| Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis. Breast cancer research and treatment 2022 Sep . Laitman Yael, Nielsen Sarah M, Bernstein-Molho Rinat, Heald Brandie, Hatchell Kathryn E, Esplin Edward D, Friedman Eit |
| Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 9 . Lucas Aimee L, Fu Yichun, Labiner Arielle J, Dimaio Christopher J, Sethi Amrita, Kastrinos F |
| Germline variants associated with breast cancer in Khakass women of North Asia. Molecular biology reports 2022 12 50 (3): 2335-2341. Gervas Polina, Molokov Aleksey, Zarubin Aleksei, Topolnitskiy Evgenii, Shefer Nikolay, Pisareva Lubov, Choynzonov Evgeny, Cherdyntseva Nadez |
| The performance of multi-gene panels for breast/ovarian cancer predisposition. Clinica chimica acta; international journal of clinical chemistry 2022 12 539 151-161. Nunziato Marcella, Scaglione Giovanni Luca, Di Maggio Federica, Nardelli Carmela, Capoluongo Ettore, Salvatore Frances |
| Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease. European journal of cancer (Oxford, England : 1990) 2022 12 179 76-86. Jiao Yue, Truong Thérèse, Eon-Marchais Séverine, Mebirouk Noura, Caputo Sandrine M, Dondon Marie-Gabrielle, Karimi Mojgan, Le Gal Dorothée, Beauvallet Juana, Le Floch Édith, Dandine-Roulland Claire, Bacq-Daian Delphine, Olaso Robert, Albuisson Juliette, Audebert-Bellanger Séverine, Berthet Pascaline, Bonadona Valérie, Buecher Bruno, Caron Olivier, Cavaillé Mathias, Chiesa Jean, Colas Chrystelle, Collonge-Rame Marie-Agnès, Coupier Isabelle, Delnatte Capucine, De Pauw Antoine, Dreyfus Hélène, Fert-Ferrer Sandra, Gauthier-Villars Marion, Gesta Paul, Giraud Sophie, Gladieff Laurence, Golmard Lisa, Lasset Christine, Lejeune-Dumoulin Sophie, Léoné Mélanie, Limacher Jean-Marc, Lortholary Alain, Luporsi Élisabeth, Mari Véronique, Maugard Christine M, Mortemousque Isabelle, Mouret-Fourme Emmanuelle, Nambot Sophie, Noguès Catherine, Popovici Cornel, Prieur Fabienne, Pujol Pascal, Sevenet Nicolas, Sobol Hagay, Toulas Christine, Uhrhammer Nancy, Vaur Dominique, Venat Laurence, Boland-Augé Anne, Guénel Pascal, Deleuze Jean-François, Stoppa-Lyonnet Dominique, Andrieu Nadine, Lesueur Fabien |
| Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. Journal of Cancer 2023 5 14 (7): 1216-1222. Jeong Eun Kim, Song Ee Park, Hee Jun Kim, In Gyu Hwa |
| Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases. Pathology, research and practice 2023 5 247 154514. M Arranz-Ledo, E Lastra, L Abella, R Ferreira, M Orozco, L Hernández, N Martínez, M Infante, M Dur |
| Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. JAMA oncology 2023 5 . Xuan Chen, Margaret A Meyer, Jennifer L Kemppainen, Masayasu Horibe, Shruti Chandra, Shounak Majumder, Gloria M Petersen, Kari G Ra |
| Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy. Human genomics 2023 5 17 (1): 43. Nermine H Zakaria, Doaa Hashad, Marwa H Saied, Neamat Hegazy, Alyaa Elkayal, Eman Tay |
| Clonal Hematopoiesis in Young Women Treated for Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Christopher J Gibson, Geoffrey G Fell, Tal Sella, Adam S Sperling, Craig Snow, Shoshana M Rosenberg, Gregory Kirkner, Ashka Patel, Deborah Dillon, Alexander G Bick, Donna Neuberg, Ann H Partridge, Peter G Mill |
| What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine 2023 4 . Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Meiting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Xin |
| The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast cancer research and treatment 2023 4 . Mary B Daly, Eric Rosenthal, Shelly Cummings, Ryan Bernhisel, John Kidd, Elisha Hughes, Alexander Gutin, Stephanie Meek, Thomas P Slavin, Allison W Kuri |
| Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancer. Journal of medical genetics 2023 4 . Evans D Gareth, Burghel George J, Schlecht Helene, Harkness Elaine F, Gandhi Ashu, Howell Sacha J, Howell Anthony, Forde Claire, Lalloo Fiona, Newman William G, Smith Miriam Jane, Woodward Emma Rois |
| Association of ATM, CDH1 and TP53 genes polymorphisms with familial breast cancer in patients of Khyber Pakhtunkhwa, Pakistan. African health sciences 2023 3 22 (3): 145-154. Rahim Abdur, Zakiullah , Jan Asif, Ali Johar, Khuda Fazli, Muhammad Basir, Khan Hamayun, Shah Hussain, Akbar Ra |
| Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study. Breast cancer (Tokyo, Japan) 2023 3 . Kikuchi Mari, Gomi Naoya, Ueki Arisa, Osako Tomo, Terauchi Takas |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 525-530. Sukpan Panupong, Kanokwiroon Kanyanatt, Sriplung Hutcha, Laochareonsuk Wison, Choochuen Pongsakorn, Auseng Nasuha, Wanawanakorn Kasemsun, Sangkhathat Suras |
| The impact of coding germline variants on contralateral breast cancer risk and survival. American journal of human genetics 2023 2 110 (3): 475-486. Morra Anna, Mavaddat Nasim, Muranen Taru A, Ahearn Thomas U, Allen Jamie, Andrulis Irene L, Auvinen Päivi, Becher Heiko, Behrens Sabine, Blomqvist Carl, Bojesen Stig E, Bolla Manjeet K, Brauch Hiltrud, Camp Nicola J, Carvalho Sara, Castelao Jose E, Cessna Melissa H, Chang-Claude Jenny, Chenevix-Trench Georgia, , Czene Kamila, Decker Brennan, Dennis Joe, Dörk Thilo, Dorling Leila, Dunning Alison M, Ekici Arif B, Eriksson Mikael, Evans D Gareth, Fasching Peter A, Figueroa Jonine D, Flyger Henrik, Gago-Dominguez Manuela, García-Closas Montserrat, Geurts-Giele Willemina R R, Giles Graham G, Guénel Pascal, Gündert Melanie, Hahnen Eric, Hall Per, Hamann Ute, Harrington Patricia A, He Wei, Heikkilä Päivi, Hooning Maartje J, Hoppe Reiner, Howell Anthony, Humphreys Keith, , Jakubowska Anna, Jung Audrey Y, Keeman Renske, Kristensen Vessela N, Lubi?ski Jan, Mannermaa Arto, Manoochehri Mehdi, Manoukian Siranoush, Margolin Sara, Mavroudis Dimitrios, Milne Roger L, Mulligan Anna Marie, Newman William G, Park-Simon Tjoung-Won, Peterlongo Paolo, Pharoah Paul D P, Rhenius Valerie, Saloustros Emmanouil, Sawyer Elinor J, Schmutzler Rita K, Shah Mitul, Spurdle Amanda B, Tomlinson Ian, Truong Thérèse, van Veen Elke M, Vreeswijk Maaike P G, Wang Qin, Wendt Camilla, Yang Xiaohong R, Nevanlinna Heli, Devilee Peter, Easton Douglas F, Schmidt Marjanka |
| Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI compass 2023 2 4 (2): 156-163. Mian Abrar, Wei Jun, Shi Zhuqing, Rifkin Andrew S, Zheng S Lilly, Glaser Alexander P, Kearns James T, Helfand Brian T, Xu Jianfe |
| HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment. Cancers 2023 2 15 (3): . Novillo Apolonia, Gaibar María, Romero-Lorca Alicia, Malón Diego, Antón Beatriz, Moreno Amalia, Fernández-Santander A |
| Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 1 JCO2201239. Yadav Siddhartha, Boddicker Nicholas J, Na Jie, Polley Eric C, Hu Chunling, Hart Steven N, Gnanaolivu Rohan D, Larson Nicole, Holtegaard Susan, Huang Huaizhi, Dunn Carolyn A, Teras Lauren R, Patel Alpa V, Lacey James V, Neuhausen Susan L, Martinez Elena, Haiman Christopher, Chen Fei, Ruddy Kathryn J, Olson Janet E, John Esther M, Kurian Allison W, Sandler Dale P, O'Brien Katie M, Taylor Jack A, Weinberg Clarice R, Anton-Culver Hoda, Ziogas Argyrios, Zirpoli Gary, Goldgar David E, Palmer Julie R, Domchek Susan M, Weitzel Jeffrey N, Nathanson Katherine L, Kraft Peter, Couch Fergus |
| Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Human genomics 2023 1 17 (1): 2. Kim Jinyong, Jeong Kyeonghun, Jun Hyeji, Kim Kwangsoo, Bae Jeong Mo, Song Myung Geun, Yi Hanbaek, Park Songyi, Woo Go-Un, Lee Dae-Won, Kim Tae-Yong, Lee Kyung-Hun, Im Seock- |
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Genes 2023 1 14 (1): . Nassar Auhood, Zekri Abdel-Rahman N, Kamel Mahmoud M, Elberry Mostafa H, Lotfy Mai M, Seadawy Mohamed G, Hassan Zeinab K, Soliman Hany K, Lymona Ahmed M, Youssef Amira Salah El-D |
| The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. Cancers 2023 1 15 (2): . Larionov Alexey, Fewings Eleanor, Redman James, Goldgraben Mae, Clark Graeme, Boice John, Concannon Patrick, Bernstein Jonine, Conti David V, The Wecare Study Collaborative Group , Tischkowitz Ma |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: